Evaluation of adverse drug reaction formatting in drug information databases.


Journal

Journal of the Medical Library Association : JMLA
ISSN: 1558-9439
Titre abrégé: J Med Libr Assoc
Pays: United States
ID NLM: 101132728

Informations de publication

Date de publication:
01 Oct 2020
Historique:
entrez: 5 10 2020
pubmed: 6 10 2020
medline: 6 8 2021
Statut: ppublish

Résumé

The research evaluated the differences in formatting of adverse drug reaction (ADR) information in drug monographs in commonly used drug information (DI) databases. A cross-sectional analysis of formatting of ADR information for twenty commonly prescribed oral medications in seven commonly used DI databases was performed. Databases were assessed for presentation of ADR information, including presence of placebo comparisons, severity of ADR, onset of ADR, formatting of ADRs in percentile (quantitative) format or qualitative format, whether references were used to cite information, whether ADRs are grouped by organ system, and word count of the ADR section. Data were collected by two study investigators and discrepancies were resolved via consensus. Chi-square analyses and one-way analysis of variance (ANOVA) were used to evaluate for mean group differences in categorical and continuous data, respectively. The seven DI databases varied significantly on each analyzed ADR variable, including variables known to impact interpretation such as placebo comparisons and qualitative versus quantitative formatting. Placebo comparisons were most common among monographs in Micromedex In-Depth Answers (70%) but were absent among monographs in Epocrates, Lexicomp, and Micromedex. Quantitative information was commonly used in most databases but was absent in Epocrates. Average word counts were higher in Clinical Pharmacology and Micromedex In-Depth answers compared to other databases. Substantial variation in ADR formatting exists between the most common DI databases. These differences may translate into alternative interpretations of medical information and, thus, impact clinical judgment. Further studies are needed to assess whether these differences impact clinical practice.

Identifiants

pubmed: 33013217
doi: 10.5195/jmla.2020.983
pii: jmla.2020.983
pmc: PMC7524619
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

598-604

Informations de copyright

Copyright © 2020 Sean M. McConachie, Derek Volgyi, Hannah Moore, Christopher A. Giuliano.

Références

J Pharm Pract. 2017 Jun;30(3):318-323
pubmed: 27080398
J Trauma Acute Care Surg. 2012 Dec;73(6):1484-90
pubmed: 23064610
Med Decis Making. 2011 May-Jun;31(3):432-6
pubmed: 21191122
Clin Pharmacol Ther. 1981 Aug;30(2):239-45
pubmed: 7249508
Ann Behav Med. 2014 Dec;48(3):311-22
pubmed: 24682975
J Gen Intern Med. 1999 Oct;14(10):633-42
pubmed: 10571710
Farm Hosp. 2019 Jul 01;43(4):128-133
pubmed: 31276445
Psychol Health Med. 2013;18(6):645-53
pubmed: 23387993
Med Decis Making. 1985 Winter;5(4):453-63
pubmed: 3842425
Int J Clin Pharm. 2018 Aug;40(4):903-910
pubmed: 30051231
Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1139-54
pubmed: 22761169
Med Decis Making. 2007 Sep-Oct;27(5):696-713
pubmed: 17873259
Cureus. 2018 Jun 22;10(6):e2860
pubmed: 30148013
J Med Libr Assoc. 2020 Jan;108(1):76-83
pubmed: 31897054
Med Decis Making. 2015 Nov;35(8):937-47
pubmed: 25952743
Eur J Clin Pharmacol. 2005 May;61(3):169-73
pubmed: 15827761
Ann Pharmacother. 2008 Jul;42(7):1017-25
pubmed: 18594048
J Gen Intern Med. 2011 Dec;26(12):1411-7
pubmed: 21792695
Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1562
pubmed: 31714644
BMC Med Inform Decis Mak. 2007 Mar 08;7:7
pubmed: 17346336
J Nutr Health Aging. 2013;17(8):700-5
pubmed: 24097025
Arch Intern Med. 2006 Mar 13;166(5):565-71
pubmed: 16534045
Psychol Rep. 2015 Oct;117(2):508-22
pubmed: 26444837
Br J Clin Pharmacol. 2007 Oct;64(4):482-8
pubmed: 17711539
Am J Health Syst Pharm. 1997 Nov 15;54(22):2592-6
pubmed: 9397221
N Engl J Med. 1982 May 27;306(21):1259-62
pubmed: 7070445
Can J Hosp Pharm. 2010 Mar;63(2):130-7
pubmed: 22478968
Pharm Pract (Granada). 2013 Apr;11(2):71-80
pubmed: 24155853

Auteurs

Sean M McConachie (SM)

et6398@wayne.edu, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, and, Beaumont Hospital, Dearborn, MI.

Derek Volgyi (D)

d.volgyi@wayne.edu, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI.

Hannah Moore (H)

fo8589@wayne.edu, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI.

Christopher A Giuliano (CA)

ek2397@wayne.edu, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, and, Ascension St. John Hospital, Dearborn, MI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH